HTA Monthly Wrap - July 2021
July 30, 2021

HTA Monthly Wrap - July 2021

Your Journey
Market Validation

The past month has been a busy time for the HealthTech Activator (HTA), with our In-depth Market Validation pilot programme coming to a successful conclusion. We also continue to build further offerings, including several new workshops later this year that will be announced in future emails and shared on our website. In the meantime, contact us for more information about our database and research support services.

Check out the news and links below to hear more about what’s been happening at the HTA, and across NZ healthtech, over the past month.


HTA News

In-Depth Market Validation: Pilot Programme Completion

From March to July 2021, five healthtech businesses working with Callaghan Innovation participated in an In-Depth Market Validation pilot programme, covering several phases of work aimed to support their commercialisation journey. 

The pilot involved workshops, remote coaching, and interviews to help companies validate their markets. The five companies received insights from the HTA’s Global Data offering, access to GLG expert interviews, and other network support from the HTA and NZTE.

On the 5th of July, we held a showcase for the companies to present the value they derived from the pilot and the next steps on their journey. The showcase was a resounding success and the feedback the HTA received has informed the development of the next programme. 

The HTA will open expressions of interest for the Feb 2022 In-Depth Market Validation cohort in September. Keep an eye out for updates, and contact us if you’d like further information, including accessing Global Data and GLG Insights for validating your market.


How to Design a Clinical Development Pathway for a Medical Device

Clinical validation is central to medical device development, but there’s more to consider than just the regulator’s requirements. Kieran Jina of Pacific Channel talks about how market and stakeholder validation is not only key to understanding your commercial opportunity; it is also key to designing a clinical development programme.

Read more here.


New on the HTA Website

  • Our Articles & Reports page: We have curated articles, reports and other resources from across global healthtech, updated regularly with key insights and developments to help you stay in the know. 
  • The HTA Directory: The new HTA Directory aims to help you find service providers, investors, networks, and other organisations in healthtech that can support your commercialisation journey.


Community Insights 

Healthtech Boom:

New Zealand’s $2.85b healthtech sector

  • The HTA’s Andrew Clews and Insides Company CEO, Garth Sutherland, talk to Radio NZ about our growing healthtech sector. 

Translating Cancer Research:

Brandon Capital leads $14m investment to develop new cancer drug (NBR)

  • Otago University spinout, Amaroq Therapeutics, has secured $14m in funding to further the development of a new cancer drug.   

Aroa Aims for $100m:

Aroa Biosurgery reveals new surgical product in development for 2023 (NBR)

  • Aroa Biosurgery is expanding its manufacturing capabilities and product offerings, anticipating $100m revenues in the next 3-4 years. 

Healthtech Week Talks:

Innovation Day Presentations

  • Everyone can now access talks from the Innovation Day of Healthtech Week by following this link and registering with your name and email.

MedTech Bites: 

June/July newsletter

  • The CMDT and MedTech CoRE are co-developers of the HTA with Callaghan Innovation, and their MedTech Bites newsletter delivers interesting articles discussing developments in the NZ healthtech world.
Download PDF
Read on External Site